25-OH Vitamin D: What This Test Actually Measures

What the 25-OH Vitamin D Test Is and Why It Exists

The 25-hydroxyvitamin D test is a single blood draw that quantifies calcidiol, the storage form of vitamin D circulating in your bloodstream. Because calcidiol has a half-life of roughly two to three weeks, it captures your cumulative vitamin D exposure from the past one to two months rather than a single day's intake [1]. That stability is precisely why every major endocrine guideline points to 25-OH D, not 1,25-dihydroxyvitamin D, as the correct marker for assessing vitamin D status.

Why 25-OH D and Not 1,25(OH)₂D

Your body converts vitamin D (from skin synthesis or oral intake) into 25-OH D in the liver. The kidneys then convert a small fraction of that 25-OH D into 1,25-dihydroxyvitamin D (calcitriol), the hormonally active form. Calcitriol has a circulating half-life of only about four to six hours and is tightly regulated by parathyroid hormone (PTH), calcium, and phosphate [2]. Measuring calcitriol can actually appear normal or even elevated during deficiency because PTH rises to compensate. The Endocrine Society's 2011 Clinical Practice Guideline states: "Measurement of serum 25(OH)D, rather than 1,25(OH)₂D, should be used to evaluate vitamin D status" [3].

Two Subtypes: D2 and D3

The total 25-OH D result on most lab panels represents the sum of 25-hydroxyvitamin D2 (from ergocalciferol, plant-derived) and 25-hydroxyvitamin D3 (from cholecalciferol, animal-derived or sun-synthesized). Some assays report D2 and D3 separately, which can be useful when a patient supplements with prescription ergocalciferol (vitamin D2, 50,000 IU weekly). Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is considered the gold-standard method for distinguishing these subtypes and reducing cross-reactivity errors [4].

How Vitamin D Gets Into Your Blood

Vitamin D follows a two-step activation pathway before it reaches measurable 25-OH D levels. Understanding this pathway helps explain why your test result can vary dramatically based on geography, skin pigmentation, diet, and supplement habits.

Step 1: Skin Synthesis or Oral Absorption

Ultraviolet B (UVB) radiation at wavelengths of 290 to 315 nm converts 7-dehydrocholesterol in the epidermis to previtamin D3, which thermally isomerizes into vitamin D3 [5]. This is efficient when the solar zenith angle is low enough, roughly between 10 a.m. And 3 p.m. During spring through fall at latitudes below about 37°N. At higher latitudes during winter months, UVB intensity drops below the threshold for meaningful skin synthesis. A 2011 analysis in the Journal of Clinical Endocrinology & Metabolism estimated that adults in Boston (42°N) produce virtually no cutaneous vitamin D3 from November through February [6].

Dietary sources (fatty fish, fortified milk, egg yolks) and supplements provide vitamin D2 or D3 that is absorbed in the small intestine along with dietary fat.

Step 2: Hepatic 25-Hydroxylation

Whether vitamin D arrives through the skin or the gut, it binds to vitamin D-binding protein and travels to the liver. Hepatic enzymes (primarily CYP2R1) hydroxylate it at the carbon-25 position, producing 25-OH D [2]. This is the molecule the blood test measures. The rate of this conversion is largely substrate-driven, meaning more vitamin D input leads to more 25-OH D output, which is exactly why the test works as a reliable gauge of total body stores.

Normal Ranges and What the Numbers Mean

The definition of "normal" 25-OH D varies by guideline, and the disagreement between major organizations is clinically significant. Knowing which reference range your provider uses matters for interpreting your result.

The IOM vs. Endocrine Society Split

The Institute of Medicine (now the National Academies of Sciences) set its recommended dietary allowance based on a sufficiency threshold of 20 ng/mL (50 nmol/L), targeting bone health in the general population [7]. The Endocrine Society's Clinical Practice Guideline recommends 30 ng/mL (75 nmol/L) as the minimum for sufficiency and suggests that 40 to 60 ng/mL may be ideal for patients at risk of deficiency [3]. The American Association of Clinical Endocrinology (AACE) aligns with the Endocrine Society, recommending a target of 30 ng/mL or higher [8].

A practical way to interpret your result:

| 25-OH D Level | IOM Classification | Endocrine Society Classification | |---|---|---| | <12 ng/mL (<30 nmol/L) | Deficient | Severely deficient | | 12 to 19 ng/mL (30 to 49 nmol/L) | Inadequate | Deficient | | 20 to 29 ng/mL (50 to 72 nmol/L) | Sufficient | Insufficient | | 30 to 100 ng/mL (75 to 250 nmol/L) | Sufficient | Sufficient | | >100 ng/mL (>250 nmol/L) | Potentially harmful | Potentially harmful | | >150 ng/mL (>375 nmol/L) | Toxic | Toxic |

How Common Is Deficiency?

A nationally representative analysis of NHANES data found that approximately 41.6% of U.S. Adults had serum 25-OH D levels below 20 ng/mL [9]. Prevalence was highest among non-Hispanic Black adults (82.1%) and Hispanic adults (69.2%), driven in part by higher melanin content reducing UVB-mediated skin synthesis. Obesity (BMI ≥30) also increases risk because vitamin D, a fat-soluble secosteroid, sequesters in adipose tissue and is less bioavailable.

Why Your Doctor Orders This Test

The 25-OH D test is not part of a standard annual metabolic panel. Ordering it typically requires a clinical indication, though practices vary by payer and provider preference.

Guideline-Supported Indications

The Endocrine Society recommends screening in individuals at risk for deficiency rather than universal population screening [3]. At-risk groups include:

• People with osteoporosis or a history of low-trauma fracture
• Patients with chronic kidney disease (stages 3 to 5)
• Those with malabsorptive conditions (celiac disease, Crohn's disease, gastric bypass)
• Individuals on medications that accelerate vitamin D catabolism (glucocorticoids, anticonvulsants like phenytoin, antiretrovirals)
• Pregnant and lactating women
• Older adults (age 65 and above) with fall risk
• People with obesity (BMI ≥30)
• Individuals with limited sun exposure or darker skin pigmentation

The USPSTF, by contrast, found insufficient evidence in 2021 to recommend routine vitamin D screening in asymptomatic adults without known risk factors [10].

What Happens After an Abnormal Result

A low result triggers a conversation about supplementation dose and duration. A result below 20 ng/mL often leads to a loading protocol of 50,000 IU ergocalciferol (D2) weekly for 8 weeks, followed by a maintenance dose of 1,000 to 2,000 IU daily [3]. An elevated PTH alongside low 25-OH D strengthens the case for secondary hyperparathyroidism, warranting calcium and phosphate checks. An unexpectedly high result (above 100 ng/mL) in someone not taking megadoses should prompt investigation for granulomatous disease or occult lymphoma, conditions where extrarenal 1-alpha-hydroxylase activity can drive excessive calcitriol production [11].

How to Raise a Low 25-OH Vitamin D Level

Correcting deficiency involves supplementation, dietary adjustments, and safe UVB exposure. The approach depends on how low the starting level is.

Supplementation Protocols

For frank deficiency (below 20 ng/mL), the Endocrine Society recommends 50,000 IU of vitamin D2 or D3 once weekly for 6 to 8 weeks, then maintenance at 1,500 to 2,000 IU daily [3]. A 2012 meta-analysis published in The American Journal of Clinical Nutrition found that vitamin D3 is approximately 87% more effective than D2 at raising and sustaining serum 25-OH D levels, especially at high bolus doses [12]. For that reason, many clinicians prefer cholecalciferol (D3) for both loading and maintenance.

Dr. Michael Holick, professor of medicine at Boston University, has noted: "Vitamin D3 is the preferred form for correcting deficiency because it more effectively raises and maintains 25-hydroxyvitamin D concentrations" [13].

Dietary and Lifestyle Measures

Fatty fish (salmon, mackerel, sardines) provide 400 to 1,000 IU per 3.5 oz serving. Fortified milk typically adds 100 IU per 8 oz cup. Cod liver oil contains roughly 1,360 IU per tablespoon [14]. These sources help with maintenance but rarely correct established deficiency alone. Safe, brief sun exposure of 10 to 15 minutes on arms and legs (without sunscreen, for fair-skinned individuals) two to three times per week during peak UVB months can produce roughly 10,000 to 20,000 IU of vitamin D3, though this varies widely by latitude, season, and skin type [5].

Monitoring After Repletion

Recheck 25-OH D levels 8 to 12 weeks after initiating supplementation. The goal is to confirm the level has risen above 30 ng/mL (Endocrine Society threshold) and to adjust the maintenance dose. Patients with malabsorption or obesity may require two to three times the standard dose to achieve target levels [3].

How to Lower a High 25-OH Vitamin D Level

True vitamin D toxicity (hypervitaminosis D) is rare but dangerous. It nearly always results from prolonged intake of very high supplemental doses, not from sun exposure or diet.

When High Levels Become Dangerous

Toxicity symptoms, including hypercalcemia, nausea, vomiting, polyuria, and kidney injury, generally appear at serum 25-OH D levels above 150 ng/mL (375 nmol/L) [15]. A case series published in The New England Journal of Medicine described patients with 25-OH D levels above 200 ng/mL after months of taking 50,000 to 100,000 IU daily, resulting in symptomatic hypercalcemia requiring IV saline and bisphosphonate therapy [16].

Steps to Reduce Elevated 25-OH D

The first step is stopping all vitamin D supplements immediately. Because 25-OH D has a half-life of two to three weeks, levels decline gradually over one to two months after cessation. Hydration is important. In severe cases (serum calcium above 14 mg/dL or acute kidney injury), hospital admission for IV normal saline, calcitonin, and possibly zoledronic acid may be required [15]. Glucocorticoids (prednisone 20 to 40 mg daily for one to two weeks) can reduce intestinal calcium absorption and calcitriol production in refractory cases [11]. Recheck 25-OH D and serum calcium at two-week intervals until levels normalize.

Beyond Bones: Other Roles of Vitamin D

The skeleton is the best-established target of vitamin D action, but research over the past two decades has identified vitamin D receptors (VDR) in nearly every tissue in the body, including immune cells, pancreatic beta cells, cardiomyocytes, and neurons [2].

Immune Function

Vitamin D modulates both innate and adaptive immunity. Macrophages express CYP27B1, the enzyme that locally converts 25-OH D to active 1,25(OH)₂D, which then induces antimicrobial peptides like cathelicidin [17]. A 2017 individual-patient-data meta-analysis of 25 randomized controlled trials (N=11,321) in The BMJ found that vitamin D supplementation reduced the risk of acute respiratory tract infections by 12% overall (adjusted OR 0.88, 95% CI 0.81 to 0.96) and by 70% in participants with baseline 25-OH D levels below 10 ng/mL who received daily or weekly dosing (adjusted OR 0.30, 95% CI 0.17 to 0.53) [18].

Mood and Cognitive Health

Observational studies consistently link low 25-OH D levels with higher rates of depression. A 2022 umbrella review of meta-analyses in Critical Reviews in Food Science and Nutrition reported that individuals with 25-OH D below 20 ng/mL had a 46% higher risk of depression compared to those with sufficient levels [19]. The VITAL-DEP ancillary study of the VITAL trial (N=18,353), however, found that vitamin D3 supplementation at 2,000 IU daily did not significantly reduce the incidence of clinical depression over 5.3 years of follow-up (HR 0.97, 95% CI 0.87 to 1.09) [20]. This gap between observational association and trial results remains an active area of investigation.

Musculoskeletal and Fall Prevention

Vitamin D deficiency is strongly associated with proximal muscle weakness and increased fall risk in older adults. The Endocrine Society recommends 1,000 to 2,000 IU daily for fall prevention in adults 65 and older who are at risk of deficiency [3]. A Cochrane systematic review found that vitamin D combined with calcium reduced the risk of hip fracture modestly (RR 0.84, 95% CI 0.74 to 0.96) in institutionalized older adults, though the benefit in community-dwelling populations was less clear [21].

Factors That Affect Test Accuracy

Not all 25-OH D assays are created equal, and several patient-related and laboratory-related factors can influence results.

Assay Variability

Immunoassay platforms (used in most hospital and commercial labs) can show 10 to 15% variability compared to LC-MS/MS, especially at low concentrations and in patients taking vitamin D2 [4]. The Vitamin D Standardization Program (VDSP), coordinated by the NIH Office of Dietary Supplements and the CDC, was developed to harmonize results across laboratories [22]. When comparing results over time, using the same lab and the same assay platform reduces noise.

Timing and Patient Factors

Season matters. Levels in most northern-latitude populations peak in late summer (August or September) and trough in late winter (February or March), with seasonal swings of 5 to 15 ng/mL being typical [6]. Acute illness and systemic inflammation can transiently lower 25-OH D by 10 to 40%, so measuring during a hospitalization for sepsis or major surgery may underestimate true stores [23]. Patients do not need to fast before the test, and time of day does not meaningfully affect results.

Who Should Get Tested Regularly

Annual or biannual monitoring is reasonable for patients on long-term supplementation, those with malabsorptive disorders, chronic kidney disease patients managed by nephrology, and individuals on medications known to alter vitamin D metabolism (phenytoin, carbamazepine, rifampin, some antiretrovirals) [3]. For the general population without risk factors, routine screening remains unsupported by the USPSTF as of its 2021 review [10].

Patients on high-dose repletion (50,000 IU weekly) should have a repeat 25-OH D drawn at 8 to 12 weeks to confirm the level has reached at least 30 ng/mL, followed by a maintenance-phase recheck at 3 to 6 months.